Little is known about the mechanism underlying Sacubitril/Valsartan effects in patients with heart failure (HFrEF). Aim of the study is to assess hemodynamic vs. non-hemodynamic Sacubitril/Valsartan effects by analyzing several biological and functional parameters.
Impact of Sacubitril/Valsartan on surfactant binding proteins, central sleep apneas, lung function tests and heart failure biomarkers: Hemodynamic or pleiotropism? / M. Mapelli, I. Mattavelli, E. Salvioni, C. Banfi, S. Ghilardi, F. De Martino, P. Gugliandolo, V. Mantegazza, V. Volpato, C. Basile, M.I.F. Branco Pires, V. Sassi, B. Nusca, C. Vignati, M. Contini, C. Sforza, M.L. Biondi, P. Perrone Filardi, P. Agostoni. - In: FRONTIERS IN CARDIOVASCULAR MEDICINE. - ISSN 2297-055X. - 9:(2022), pp. 971108.1-971108.10. [10.3389/fcvm.2022.971108]
Impact of Sacubitril/Valsartan on surfactant binding proteins, central sleep apneas, lung function tests and heart failure biomarkers: Hemodynamic or pleiotropism?
M. MapelliPrimo
;E. Salvioni;C. Banfi;V. Mantegazza;V. Volpato;V. Sassi;B. Nusca;C. Vignati;C. Sforza;P. AgostoniUltimo
2022
Abstract
Little is known about the mechanism underlying Sacubitril/Valsartan effects in patients with heart failure (HFrEF). Aim of the study is to assess hemodynamic vs. non-hemodynamic Sacubitril/Valsartan effects by analyzing several biological and functional parameters.
| File | Dimensione | Formato | |
|---|---|---|---|
|
fcvm-09-971108.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
792.25 kB
Formato
Adobe PDF
|
792.25 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
